As a part of the agreement, Zydus will be responsible for clinical development and regulatory approvals of licensed products in...
Read moreThe PMJAY beneficiary had been grappling with severe abdominal pain since undergoing a laparoscopic appendectomy for a perforated appendix and...
Read moreSerum Institute launches nationwide campaign to raise awareness on HPV-cancer The ‘Conquer HPV and Cancer Conclave 2025’ was launched in...
Read moreThis pioneering collaboration brings together GBU’s academic research strengths with the translation and commercialization experience of Cellimune Biotech CAR-T therapy...
Read moreThe team developed 5n, a potential prostate cancer inhibitor, to disrupt cancer’s survival tactics through molecular sabotage The molecule disables...
Read moreRevenue from operations at 6,528 crore, up 18% over last year. Research & Development (R&D) investments Rs. 479.9 crore (7.4%...
Read moreWith top recruiters on campus and a Rs 9L per annum peak offer, Swarrnim balances strong placements with a thriving...
Read moreIt is the generic version of Copaxone® 20 mg/ml, 40 mg/ml, Single-Dose Prefilled Syringes Zydus’ generic Glatiramer Acetate Injection, developed...
Read moreAlembic has a cumulative total of 222 ANDA approvals (197 final approvals and 25 tentative approvals) from USFDA NE BUSINESS...
Read moreProf. Ratan Kumar Parimu-NE photo Of them four were conferred with Padma Vibhushan, 10 with Padma...
Read moreEmail:
ne.gowri1964@gmail.com
Phone:
9643255068
Editorial and Administrative Office:
Block No 1 Flat No 4C
Wipro Street, Sholinganallur
Off Old Mabalipuram Road
Chennai 600119, Tamil nadu
96, First Floor, Srinathnagar Society,
(Landmark: Near Panchdev Mandir,
Karmacharinagar Vibhag-I),
Ghatlodia, Ahmedabad-380 061
© 2021 all right reserved by Navjeevanexpress.com. Consulted by MediaHives.com